These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35952942)

  • 1. High Perceived Stress is Associated With Increased Risk of Ulcerative Colitis Clinical Flares.
    Sauk JS; Ryu HJ; Labus JS; Khandadash A; Ahdoot AI; Lagishetty V; Katzka W; Wang H; Naliboff B; Jacobs JP; Mayer EA
    Clin Gastroenterol Hepatol; 2023 Mar; 21(3):741-749.e3. PubMed ID: 35952942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Autonomic Nervous System Measures Correlate With Stress and Ulcerative Colitis Disease Activity and Predict Flare.
    Hirten RP; Danieletto M; Scheel R; Shervey M; Ji J; Hu L; Sauk J; Chang L; Arnrich B; Bӧttinger E; Dudley J; Keefer L; Sands BE
    Inflamm Bowel Dis; 2021 Oct; 27(10):1576-1584. PubMed ID: 33382065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of mindfulness-based stress reduction to prevent flare-up in patients with inactive ulcerative colitis.
    Jedel S; Hoffman A; Merriman P; Swanson B; Voigt R; Rajan KB; Shaikh M; Li H; Keshavarzian A
    Digestion; 2014; 89(2):142-55. PubMed ID: 24557009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical factors to predict flare-up in patients with inflammatory bowel disease during international air travel: A prospective study.
    Park J; Yoon H; Shin CM; Park YS; Kim N; Lee DH
    PLoS One; 2022; 17(1):e0262571. PubMed ID: 35061808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.
    Gracie DJ; Guthrie EA; Hamlin PJ; Ford AC
    Gastroenterology; 2018 May; 154(6):1635-1646.e3. PubMed ID: 29366841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative Colitis in Clinical Remission.
    Bodini G; Ghezzi A; Pasta A; Marabotto E; Calabrese F; Facchini C; Demarzo MG; Giannini EG
    J Gastrointestin Liver Dis; 2023 Dec; 32(4):438-443. PubMed ID: 38147604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors contributing to flares of ulcerative colitis in North India- a case-control study.
    Rana VS; Mahajan G; Patil AN; Singh AK; Jearth V; Sekar A; Singh H; Saroch A; Dutta U; Sharma V
    BMC Gastroenterol; 2023 Sep; 23(1):336. PubMed ID: 37770831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship Among Perceived Stress, Symptoms, and Inflammation in Persons With Inflammatory Bowel Disease.
    Targownik LE; Sexton KA; Bernstein MT; Beatie B; Sargent M; Walker JR; Graff LA
    Am J Gastroenterol; 2015 Jul; 110(7):1001-12; quiz 1013. PubMed ID: 26077178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated - an open-label pilot study.
    Cold F; Browne PD; Günther S; Halkjaer SI; Petersen AM; Al-Gibouri Z; Hansen LH; Christensen AH
    Scand J Gastroenterol; 2019 Mar; 54(3):289-296. PubMed ID: 30946615
    [No Abstract]   [Full Text] [Related]  

  • 10. The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment.
    Theede K; Kiszka-Kanowitz M; Nielsen AM; Nordgaard-Lassen I
    Scand J Gastroenterol; 2014 Apr; 49(4):418-23. PubMed ID: 24495103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis.
    Scaioli E; Sartini A; Bellanova M; Campieri M; Festi D; Bazzoli F; Belluzzi A
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1268-1275.e2. PubMed ID: 29391271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
    World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors.
    Goodhand JR; Wahed M; Mawdsley JE; Farmer AD; Aziz Q; Rampton DS
    Inflamm Bowel Dis; 2012 Dec; 18(12):2301-9. PubMed ID: 22359369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study.
    Golovics PA; Gonczi L; Reinglas J; Verdon C; Pundir S; Afif W; Wild G; Bitton A; Bessissow T; Lakatos PL
    Dig Dis Sci; 2022 Jul; 67(7):3089-3095. PubMed ID: 34286411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of Bidirectional Associations Between Perceived Stress and Symptom Activity: A Prospective Longitudinal Investigation in Inflammatory Bowel Disease.
    Sexton KA; Walker JR; Graff LA; Bernstein MT; Beatie B; Miller N; Sargent M; Targownik LE
    Inflamm Bowel Dis; 2017 Mar; 23(3):473-483. PubMed ID: 28221251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-control study of factors that trigger inflammatory bowel disease flares.
    Feagins LA; Iqbal R; Spechler SJ
    World J Gastroenterol; 2014 Apr; 20(15):4329-34. PubMed ID: 24764669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial.
    Langhorst J; Boone J; Lauche R; Rueffer A; Dobos G
    J Crohns Colitis; 2016 Jul; 10(7):786-94. PubMed ID: 26874351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis.
    Walsh A; Kormilitzin A; Hinds C; Sexton V; Brain O; Keshav S; Uhlig H; Geddes J; Goodwin G; Peters M; Collins G; Travis S
    J Crohns Colitis; 2019 Mar; 13(4):424-430. PubMed ID: 30445625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mindfulness Intervention Decreases Frequency and Severity of Flares in Inactive Ulcerative Colitis Patients: Results of a Phase II, Randomized, Placebo-Controlled Trial.
    Jedel S; Beck T; Swanson G; Hood MM; Voigt RM; Gorenz A; Jakate S; Raeisi S; Hobfoll S; Keshavarzian A
    Inflamm Bowel Dis; 2022 Dec; 28(12):1872-1892. PubMed ID: 35661212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.